Early Aubagio ‘preferable for preventing disease progression’
Early Aubagio reduces disability progression more significantly than delayed treatment in patients with multiple sclerosis (MS), according to results from the phase three TOWER study and its open-label extension phase, presented at the 2015 Annual Meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)... Read more - http://www.ms-uk.org/MSnews
Early Aubagio ‘preferable for preventing disease progression
Early Aubagio ‘preferable for preventing disease progression
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2505 Views
-
Last post by NHE
-
- 0 Replies
- 1178 Views
-
Last post by frodo
-
- 0 Replies
- 1118 Views
-
Last post by NHE
-
- 0 Replies
- 1297 Views
-
Last post by frodo
-
- 0 Replies
- 1432 Views
-
Last post by NHE
-
- 0 Replies
- 1169 Views
-
Last post by frodo
-
- 0 Replies
- 1508 Views
-
Last post by NHE
-
- 0 Replies
- 1780 Views
-
Last post by DIM
-
- 0 Replies
- 1413 Views
-
Last post by NHE